Three femtosecond laser comparisons: IntraLase FS30 comes out on top
September 11th 2006The IntraLase femtosecond FS30 laser creates a more predictable and more stable flap thickness than the Hansatome XP microkeratome (Bausch & Lomb) and the IntraLase femtosecond FS2 laser, according to research conducted by Baha Toygar and colleagues from Turkey.
Monofocal, multifocal or accommodative IOL: which is best?
September 11th 2006Among the different IOL options for presbyopia, monofocals are probably by far the most practically used ones said Thomas Neuhann. He added that competing options must be able to beat an already high level of success and patient satisfaction.
Pressure instability could explain pumping phenomena in cataract surgery
September 11th 2006Instability in the pressure line could explain the pumping phenomena sometimes reported during cataract surgery, according to Carlos Verges, Jorge Cazal and Cosme Lavin of the Department of Ophthalmology, Institut Universitari Dexeus, Barcelona, Spain.
Extra care essential for cataract with ocular surface disease
September 10th 2006Great care and detailed assessment are essential for cataract extractions where another ocular surface disease (OSD) is present, Thomas Neuhann said. Diseases range from dry eye, conjuntivalisation, irregular surfaces and corneal scars.
ReSTOR IOL good in post LASIK cataract patients
September 10th 2006The use of the ReSTOR intraocular lens (IOL) (Alcon) for patients requiring cataract surgery after prior laser photoablation can result in excellent outcomes if optical results fall near emmetropia, according to Samuel Masket of the USA.
Blue light-blocking IOLs unnecessary
September 10th 2006There is no current proof that blocking blue wavelengths guarantees retinal protection and, couple this with the fact that blocking this form of light causes an actual loss in visual quality, Alessandro Franchini MD, suggests we concentrate our efforts on blocking UV and violet radiations instead.
Intraoperative online pachymetry important safety feature
September 10th 2006An initial clinical evaluation of the new ESIRIS excimer laser with integrated, online, optical coherence pachymetry (Schwind), showed that constant corneal monitoring is an important safety feature for LASIK procedures, Kumar J. Doctor said.
Promising results for new quality of vision metric
September 9th 2006It is mandatory to develop precise , reproducible and accurate methodologies to obtain objective measurements of quality of vision, namely night vision, in order to create surgical techniques that will eliminate post-refractive vision disturbances, Joachim Murta said.
Can we quantify the quality of vision?
September 9th 2006The age of refractive surgery has introduced new aberrations to the human eye that require a shift in how visual performance is evaluated, said Ray Applegate, MD. Mesopic low contrast acuity best quantifies vision quality; it overcomes the weaknesses of other metrics and it can predict visual function among individuals.
Good pseudoaccommodation with MICS lens at one year
September 9th 2006The new MICS lens (Ioltech-Zeiss) is appropriate for the correction of intermediate vision in pseudophakia, according to Carlos Verges, Jorge Cazal and Marc Menezo of the Department of Ophthalmology, Institut Universitari Dexeus, Barcelona, Spain.
Phase I trials start for anti-angiogenic eye drop therapy for AMD
September 8th 2006Athenagen Inc. began a phase I clinical trial of mecamylamine (ATG003), its eye drop therapy for age-related macular degeneration (AMD). Animal models showed efficacy of ATG003 as an alternative to current AMD therapies, which require needle injections directly in the eye. The randomized, placebo-controlled, ascending dose clinical trial is designed to evaluate ocular tolerability and safety for up to 14 days.
Associations advise cataract patients on risks of alpha-blockers
September 8th 2006The American Society of Cataract and Refractive Surgery (ASCRS), American Academy of Ophthalmology, and American Urological Association all encouraged cataract patients to talk about medications, mainly alpha-blockers, used for benign prostatic hyperplasia and certain types of lower urinary tract symptoms before undergoing cataract surgery.
Health officials report on Fusarium keratitis outbreak
September 8th 2006The 164 confirmed cases of Fusarium keratitis in 33 states and one U.S. territory were due to the use of Bausch & Lomb Inc.’s ReNu with MoistureLoc contact lens solution, according to a report by the Fusarium Keratits Investigation Team in the Journal of the American Medical Association (JAMA) (2006; 296:953-963). The team went on to discourage contact lens users from using that product.